FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula , wherein A represents CRaRb or -CH2-CH2-; R1 represents hydrogen or alkyl; R2 represents hydrogen or alkyl; R3 represents alkyl, cycloalkyl, cycloalkylalkyl, aryl, substituted aryl, 1H-pyrazolyl or substituted 1H-pyrazolyl, wherein substituted aryl represents aryl substituted by 1-3 substitutes independently specified in alkyl, halogen and halogenalkyl, and wherein substituted 1H-pyrazolyl represents 1H-pyrazolyl substituted by 1-3 substitutes independently specified in alkyl and aryl; Ra represents hydrogen or methyl; Rb represents hydrogen or methyl; or Ra and Rb together with a carbon atom, to which they are attached, form cyclopropyl, cyclobutyl or cyclopentyl; provided Ra and Rb both represent hydrogen, or both represent methyl simultaneously, R3 represents (1-methylcyclopropyl)methyl, which possess the inhibitory action on 11b-HSD1.
EFFECT: preparing the compounds, which possess the inhibitory action on 11b-HSD1.
15 cl, 1 tbl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
ALKYL-PYRIDAZINE DERIVATIVES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1(11β-HSD 1) | 2007 |
|
RU2417989C2 |
PYRAZOLONE DERIVATIVES | 2006 |
|
RU2407737C2 |
CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2729636C2 |
THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY | 2014 |
|
RU2703273C2 |
MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS | 2019 |
|
RU2778294C2 |
PYRIMIDINE DERIVATIVES WITH INHIBITING ACTION WITH RESPECT TO 11b-HSD1 | 2005 |
|
RU2375351C2 |
9-(SUBSTITUTED GLYCYL)AMIDO-6-DIMETHYL 6- DEOXYTETRACYCLINE, METHOD OF PREPARATION THEREOF, INTERMEDIATE PRODUCT, METHOD OF PREPARATION THEREOF, ANTIBACTERIAL COMPOSITION, AND METHOD OF ANTIBACTERIAL EFFECT | 1993 |
|
RU2123999C1 |
NEW AZACYCLIC COMPOUNDS | 2011 |
|
RU2603263C2 |
2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
Authors
Dates
2015-02-20—Published
2009-07-06—Filed